Connect with us

Hi, what are you looking for?

News

U.S. IPO Weekly Recap: Tech IPOs Pop As End Of March Approaches

Four IPOs priced this past week, joined by one SPAC.

After upping its terms at the start of the week, chipmaker Astera Labs (ALAB) priced above the raised range to raise $713 million at a $6.3

5 IPOs During the Week of March 18th, 2024
Issuer Business Deal Size Market Cap at IPO Price vs. Midpoint First Day Return Return at 03/22

Astera Labs (ALAB)

$713M $6,340M 26% +72% +94%
Designs advanced chip-based connectivity products used in data centers.

Reddit (RDDT)

$748M $6,370M 5% +48% +35%
Social media platform with message boards for interest-based communities.

Black Hawk Acquisition (BKHAU)

$69M $89M 0% +2% +2%
Blank check company targeting businesses with growth potential and defensible market positions.

Auna (AUNA)

$360M $903M -14% -20% -20%
Provides healthcare plans and operates hospitals in Peru, Colombia, and Mexico.

Intelligent Group (INTJ)

$8M $53M -11% -18% -47%
Provides financial public relations consulting in Hong Kong.

4 Filings During the Week of March 18th, 2024
Issuer Business Deal Size Sector Lead Underwriter

Centuri (CTRI)

$500M Industrials UBS
Carve-out of Southwest Gas providing infrastructure services to energy and utility firms.

Churchill Capital IX (CCIXU)

$250M SPAC Citi
Blank check company founded by dealmaker and former Citi executive Michael Klein.

Ibotta (IBTA)

$250M Technology Goldman
Provides a digital marketing platform that offers consumers cash rebates.

NANO Nuclear Energy (NNE)

$15M Industrials Benchmark
Developing nuclear microreactors and related fuel technologies.

U.S. IPO Calendar
Issuer Business Deal Size Market Cap Price Range Shares Filed Top Bookrunners

Mobile-Health Network (MNDR)

$10M

$153M

$4 – $5

2,250,000

Network 1
Provides a platform for telehealth and other healthcare services in the APAC region.

Alta Global Group (MMA)

Manly, Australia

$7M

$58M

$4 – $6

1,300,000

ThinkEquity
Provides martial arts and combat sport training through a network of partner gyms.

Boundless Bio (BOLD)

San Diego, CA

$100M

$396M

$15 – $17

6,250,000

Goldman

Leerink Partners

Phase 1 biotech developing inhibitor therapies for oncogene-amplified tumors.

Read the full article here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Videos

Watch full video on YouTube